Concepedia

C. Dansirikul

CD

6

Publications

510

Citations

6

H-Index

2004

Active since

Affiliations

The University of Queensland(Current)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (United States)

Uppsala University

C. Dansirikul is an author at The University of Queensland specializing in pharmacology, medicine, and pharmacokinetics.

Top concepts

MedicinePharmacologyPharmacokineticsCardiologyHematologyHepatologyThrombosisBioanalysisBiostatisticsDrug Analysis

Publications per year

2004–2017

6

Publications

6

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial

Karl‐Heinz Liesenfeld, Thorsten Lehr, C. Dansirikul et al. · Journal of Thrombosis and Haemostasis · 2011 · 302 citations · Full text

Thrombosis, Cardiovascular Disease, Medicine +10

Approaches to handling pharmacodynamic baseline responses

C. Dansirikul, Hanna E. Silber, Mats O. Karlsson · Journal of Pharmacokinetics and Pharmacodynamics · 2008 · 76 citations

Pharmacology, Pharmacodynamic Baseline Responses, Medicine +2

A Bayesian approach for population pharmacokinetic modelling of sirolimus

C. Dansirikul, Raymond G. Morris, Susan E. Tett et al. · British Journal of Clinical Pharmacology · 2005 · 41 citations · Full text

Estimation of pharmacokinetic parameters from non-compartmental variables using Microsoft Excel®

C. Dansirikul, Malcolm Choi, Stephen B. Duffull · Computers in Biology and Medicine · 2004 · 37 citations

Molecular Pharmacology, Pharmacokinetic Modeling, Medicine +5

A phase I, randomized, proof‐of‐clinical‐mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral <scp>PDE9A</scp> inhibitor <scp>BI</scp> 409306 in healthy male volunteers

Katja Boland, Viktoria Moschetti, C. Dansirikul et al. · Human Psychopharmacology Clinical and Experimental · 2017 · 29 citations

Rows per page

1–5 of 6